Citation analysis for Briefings / Office of Health Economics

Briefings / Office of Health Economics

null

Impact Factor

null

5-Years IF

5-Years H index

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ]
[more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw data

	IF	AIF	IF5	DOC	CDO	CCU	CIF	CIT	D2Y	C2Y	D5Y	C5Y	%SC	CiY	II	AII
1990		0.11		3	3				3		4		(%)			0.06
1991		0.1		2	5				4		6		(%)			0.04
1992		0.1		1	6				5		8		(%)			0.05
1993		0.13		1	7				3		9		(%)			0.06
1994		0.14		2	9				2		8		(%)			0.06
1995		0.17		1	10			5	3		9		(%)			0.1
1996		0.22			10				3		7		(%)			0.09
1997		0.22		3	13			2	1		5		(%)			0.09
1998	0.33	0.24	0.14	3	16	1	0.06		3	1	7	1	(%)			0.12
1999		0.3			16				6		9		(%)			0.15
2000		0.36	0.14		16	1	0.06		3		7	1	(%)			0.14
2001		0.36			16				0		6		(%)			0.16
2002		0.37			16				0		6		(%)			0.18
2003		0.39		1	17			1	0		3		(%)			0.19
2004	1	0.4	1	1	18	1	0.06	1	1	1	1	1	(%)			0.18
2005		0.42			18	2	0.11		2		2		(%)			0.2
2006		0.45		2	20	1	0.05		1		2		(%)			0.19
2007		0.38		1	21	1	0.05		2		4		(%)			0.16
2008		0.39	0.2	5	26	1	0.04	14	3		5	1	2 (14.3%)			0.17
2009	0.17	0.36	0.11	6	32	2	0.06	21	6	1	9	1	(%)	1	0.17	0.17
2010	0.55	0.34	0.43		32	7	0.22		11	6	14	6	(%)			0.15
2011	0.17	0.4	0.07		32	1	0.03		6	1	14	1	(%)			0.19
2012		0.44	0.17	1	33	2	0.06		0		12	2	(%)			0.2
2013		0.49	0.58		33	8	0.24		1		12	7	(%)			0.2
2014		0.52	0.57	1	34	10	0.29		1		7	4	(%)			0.23
2015		0.54		1	35	2	0.06		1		2		(%)			0.24
2016		0.6		2	37	2	0.05		2		3		(%)			0.27
2017		0.64		7	44	5	0.11	4	3		5		3 (75%)	4	0.57	0.28

IF:	Impact Factor: C2Y / D2Y
AIF:	Average Impact Factor for series in RePEc in year y
IF5:	Impact Factor: C5Y / D5Y
DOC:	Number of documents published in year y
CDO:	Cumulative number of documents published until year y
CCU:	Cumulative number of citations to papers published until year y
CIF:	Cumulative impact factor
CIT:	Number of citations to papers published in year y
D2Y:	Number of articles published in y-1 plus y-2
C2Y:	Cites in y to articles published in y-1 plus y-2
D5Y:	Number of articles published in y-1 until y-5
C5Y:	Cites in y to articles published in y-1 until y-5
%SC:	Percentage of selft citations in y to articles published in y-1 plus y-2
CiY:	Cites in year y to documents published in year y
II:	Immediacy Index: CiY / Documents.
AII:	Average Immediacy Index for series in RePEc in year y

50 most cited documents in this series:

#	Year	Title	Cited
1	2009	Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?. (2009). Johannesson, Magnus ; Zethraeus, N ; Kobelt, G ; Jonsson, L. In: Briefings. RePEc:ohe:briefg:000228. Full description at Econpapers \|\| Download paper	11
2	2009	Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries. (2009). Garau, Martina ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000227. Full description at Econpapers \|\| Download paper	6
3	2008	The Market for Biosimilars: Evolution and Policy Options. (2008). Towse, Adrian ; Chauhan, D ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000238. Full description at Econpapers \|\| Download paper	6
4	1995	Handling Uncertainty in the Results of Economic Evaluation. (1995). Briggs, A. In: Briefings. RePEc:ohe:briefg:000410. Full description at Econpapers \|\| Download paper	5
5	2008	New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?. (2008). Drummond, M F ; Rutten, F. In: Briefings. RePEc:ohe:briefg:000237. Full description at Econpapers \|\| Download paper	5
6	2009	American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis. (2009). Neumann, P J. In: Briefings. RePEc:ohe:briefg:000232. Full description at Econpapers \|\| Download paper	3
7	2008	Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective. (2008). Cross, J T ; Garrison, L. In: Briefings. RePEc:ohe:briefg:000239. Full description at Econpapers \|\| Download paper	2
8	2017	Additional Elements of Value for Health Technology Assessment Decisions. (2017). Towse, Adrian ; Karlsberg, Sarah ; Schaffer, Karlsberg S ; Fischer, A ; Masterson, R ; Mestre-Ferrandiz, J ; Henshall, C ; West, P. In: Briefings. RePEc:ohe:briefg:001851. Full description at Econpapers \|\| Download paper	2
9	1997	Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry. (1997). Towse, Adrian ; Cave, M. In: Briefings. RePEc:ohe:briefg:000427. Full description at Econpapers \|\| Download paper	2
10	1980	Effects of Prescription Charges. (1980). Of, Office . In: Briefings. RePEc:ohe:briefg:000310. Full description at Econpapers \|\| Download paper	1
11	2004	Developments in Economic Evaluation in Health Care: A Review of HEED. (2004). Pritchard, C. In: Briefings. RePEc:ohe:briefg:000492. Full description at Econpapers \|\| Download paper	1
12	2008	Health Care Services and the Single European Market. (2008). Dawson, D ; Mountford, L. In: Briefings. RePEc:ohe:briefg:000240. Full description at Econpapers \|\| Download paper	1
13	2009	Deliberative Processes in Decisions about Health Care Technologies. (2009). Culyer, Anthony. In: Briefings. RePEc:ohe:briefg:000231. Full description at Econpapers \|\| Download paper	1
14	2003	Reducing Harm to Patients in the National Health Service. Will the Governments Compensation Proposals Help?. (2003). Towse, Adrian ; Salinas, R ; Rickman, N ; Gray, A ; Fenn, P. In: Briefings. RePEc:ohe:briefg:000484. Full description at Econpapers \|\| Download paper	1
15	2009	How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England. (2009). Sussex, J. In: Briefings. RePEc:ohe:briefg:000230. Full description at Econpapers \|\| Download paper	1
16	2017	Incentives for New Drugs to Tackle Anti-Microbial Resistance. (2017). Towse, Adrian ; Ferraro, J ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:001842. Full description at Econpapers \|\| Download paper	1
17	2017	Transferability of HTA. (2017). Towse, Adrian ; Hampson, Grace ; Barnsley, P ; Henshall, C. In: Briefings. RePEc:ohe:briefg:001837. Full description at Econpapers \|\| Download paper	1

50 most relevant documents in this series (papers most cited in the last two years)

#	Year	Title	Cited
1	2009	Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?. (2009). Johannesson, Magnus ; Zethraeus, N ; Kobelt, G ; Jonsson, L. In: Briefings. RePEc:ohe:briefg:000228. Full description at Econpapers \|\| Download paper	3
2	2017	Additional Elements of Value for Health Technology Assessment Decisions. (2017). Towse, Adrian ; Karlsberg, Sarah ; Schaffer, Karlsberg S ; Fischer, A ; Masterson, R ; Mestre-Ferrandiz, J ; Henshall, C ; West, P. In: Briefings. RePEc:ohe:briefg:001851. Full description at Econpapers \|\| Download paper	2
3	2009	Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries. (2009). Garau, Martina ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000227. Full description at Econpapers \|\| Download paper	2

Citing documents used to compute impact factor 0:

Year	Title

Recent citations (cites in year: CiY)

Recent citations received in 2017

Year	Citing document
2017	Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation. (2017). Towse, Adrian ; Rex, John H ; Hirsch, Mark ; Hoyle, Christopher K ; Mestre-Ferrandiz, Jorge ; Goodall, Jonathan. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:10:p:1025-1030. Full description at Econpapers \|\| Download paper
2017	Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C. In: Briefings. RePEc:ohe:briefg:001835. Full description at Econpapers \|\| Download paper
2017	Incentives for New Drugs to Tackle Anti-Microbial Resistance. (2017). Towse, Adrian ; Ferraro, J ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:001842. Full description at Econpapers \|\| Download paper
2017	Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?. (2017). Towse, Adrian ; Neri, Margherita. In: Briefings. RePEc:ohe:briefg:001922. Full description at Econpapers \|\| Download paper

10 most frequent citing series

#	Series	Cites
1	PharmacoEconomics / Springer	5
2	The European Journal of Health Economics / Springer	5
3	Health Policy / Elsevier	3
4	Research Papers / Office of Health Economics	3
5	Applied Health Economics and Health Policy / Springer	2
6	Seminar Briefings / Office of Health Economics	2
7	Briefings / Office of Health Economics	2
8	Social Science & Medicine / Elsevier	2
9	Health Economics / John Wiley & Sons, Ltd.	2
10	Consulting Reports / Office of Health Economics	1
11	Journal of Health Economics / Elsevier	1

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.